Charles Schwab Investment Management Inc. Has $757,000 Holdings in PetMed Express, Inc. (NASDAQ:PETS)

Charles Schwab Investment Management Inc. lowered its stake in shares of PetMed Express, Inc. (NASDAQ:PETS) by 49.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 205,635 shares of the company’s stock after selling 200,150 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.00% of PetMed Express worth $757,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of PETS. Point72 DIFC Ltd acquired a new position in shares of PetMed Express during the second quarter worth about $34,000. Marshall Wace LLP acquired a new stake in PetMed Express in the 2nd quarter valued at $46,000. SG Americas Securities LLC bought a new stake in PetMed Express during the 2nd quarter worth about $46,000. Legacy Advisors LLC bought a new position in shares of PetMed Express in the 2nd quarter valued at about $96,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in PetMed Express during the second quarter worth about $135,000. 73.33% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at PetMed Express

In other news, Director Leslie C.G. Campbell purchased 15,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was acquired at an average cost of $5.38 per share, with a total value of $80,700.00. Following the acquisition, the director now owns 70,000 shares in the company, valued at approximately $376,600. This trade represents a 27.27 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.10% of the company’s stock.

PetMed Express Stock Performance

PetMed Express stock opened at $5.28 on Thursday. The stock has a 50-day simple moving average of $4.71 and a 200 day simple moving average of $4.07. The stock has a market capitalization of $109.08 million, a P/E ratio of -88.00 and a beta of 0.71. PetMed Express, Inc. has a 52 week low of $2.90 and a 52 week high of $7.79.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.17. The business had revenue of $59.57 million during the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. Research analysts forecast that PetMed Express, Inc. will post 0.24 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised PetMed Express from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.